Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biochim Biophys Acta ; 1089(3): 345-51, 1991 Jul 23.
Artigo em Inglês | MEDLINE | ID: mdl-1859838

RESUMO

We have developed an efficient production system for porcine pancreatic phospholipase A2 in Saccharomyces cerevisiae (baker's yeast). The cDNA encoding the prophospholipase A2 was expressed under the control of the galactose inducible GAL7 promotor, and secretion was directed by the secretion signals of yeast invertase. This construct yielded up to 6 mg prophospholipase A2 activity per 1 fermentation broth, secreted as a glycosylated invertase prophospholipase A2 hybrid protein. Upon genetically deleting the glycosylation site, the level of secretion decreased to 3.6 mg prophospholipase A2 per 1. Changing the invertase secretion signals for an invertase/alpha-mating factor prepro sequence-fusion increased the secretion level up to 8 mg per 1. The secreted non-glycosylated prophospholipase A2 species was correctly processed. Our results demonstrate the promises and limitations for rational design to obtain high level expression and secretion of heterologous proteins by S. cerevisiae.


Assuntos
Pâncreas/enzimologia , Fosfolipases A/genética , Saccharomyces cerevisiae/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Western Blotting , DNA , Eletroforese em Gel de Poliacrilamida , Engenharia Genética , Glicosídeo Hidrolases/genética , Glicosídeo Hidrolases/metabolismo , Fator de Acasalamento , Dados de Sequência Molecular , Pâncreas/metabolismo , Peptídeos/genética , Peptídeos/metabolismo , Fosfolipases A/metabolismo , Fosfolipases A2 , Regiões Promotoras Genéticas , Precursores de Proteínas/metabolismo , Processamento de Proteína Pós-Traducional , Suínos , beta-Frutofuranosidase
2.
J Biol Chem ; 266(7): 4162-7, 1991 Mar 05.
Artigo em Inglês | MEDLINE | ID: mdl-1999411

RESUMO

Phospholipases A2 (PLA-2) are conserved enzymes that can vary widely in their activity toward certain biological targets. Activity of PLA-2 toward Escherichia coli treated with the bactericidal/permeability-increasing protein (BPI) of granulocytes has been detected only in "Group II" PLA-2 (lacking Cys11-Cys77) and correlates with overall basicity and the presence of a cluster of basic amino acids within a variable surface region near the NH2 terminus (including residues 6, 7, 10, 11, and 15). We now show that of five pancreatic PLA-2 ("Group I" enzymes) tested from different species of mammals, the human enzyme that is most basic both globally (pI 8.7) and locally (Arg-6, Lys-7, and Lys-10) is active toward BPI-treated E. coli (approximately 1-2% activity of the most active Group II PLA-2) whereas the other four PLA-2 are essentially inactive (less than 0.1%). The cDNA of the pig pancreatic PLA-2 (pI 6.4; Arg-6, Ser-7, Lys-10) has been modified by site-specific mutagenesis and the wild-type and mutant PLA-2 have been expressed in and purified from either E. coli or Saccharomyces cerevisiae to determine more precisely the structural determinants of PLA-2 activity toward BPI-treated E. coli. The single substitution of lysine (or arginine) for Ser-7 transformed the pig pancreatic PLA-2 into an active enzyme toward BPI-treated E. coli possessing 25-50% the activity of the human PLA-2. Additional modifications to increase global basicity (increase in net charge up to +4) caused a further (up to 2-fold) increase in activity. All mutant PLA-2 still containing Ser-7 possessed little or no activity toward BPI-treated E. coli. Changes in activity toward BPI-treated E. coli were accompanied by parallel changes in enzyme binding to this target. In contrast, substitution of lysine (or arginine) for Ser-7 caused little or no alteration of enzyme activity toward either autoclaved E. coli or egg yolk lipoproteins indicating no major effects on the catalytic properties of the PLA-2. This study demonstrates directly the role of NH2-terminal basic residues in the action of PLA-2 on BPI-treated E. coli and suggests that these properties mainly facilitate PLA-2 binding to this biological target.


Assuntos
Proteínas Sanguíneas/farmacologia , Escherichia coli/metabolismo , Proteínas de Membrana , Fosfolipases A/genética , Animais , Peptídeos Catiônicos Antimicrobianos , Análise Mutacional de DNA , Humanos , Técnicas In Vitro , Cinética , Pâncreas/enzimologia , Fosfolipases A/metabolismo , Fosfolipases A2 , Engenharia de Proteínas , Relação Estrutura-Atividade , Suínos
3.
Prog Clin Biol Res ; 349: 1-9, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2204927

RESUMO

Deacylating phospholipases play essential roles in numerous biological events, requiring tight control of hydrolytic activity. Most cells, unless stimulated or perturbed, exhibit little phospholipid turnover. Activation of phospholipases A (PLA) is usually triggered by membrane perturbing conditions or agents. Some activators indiscriminately activate any PLA, others are highly specific. Our studies concern an activator that is a potent bactericidal protein with membrane-perturbing properties, isolated from polymorphonuclear leukocytes (PMN), that is only cytotoxic for gram-negative bacteria and primarily responsible for the fate of several gram-negative bacterial species, ingested and killed by the PMN. It is this protein that activates the hydrolysis of the phospholipids of the killed bacteria (E. coli) by three PLA: 1) an E. coli PLA, the pldA gene product; 2) a PLA2 of PMN; 3) a soluble PLA2 in the extracellular fluid of an inflammatory exudate. However, this activator protein does not trigger the action of many other PLA2, all members of a highly conserved class of PLA. Our structural studies (including genetic engineering) of both responsive and non-responsive PLA2 have revealed that the amino acid composition and sequence of the NH2-terminal alpha-helix of the PLA2 molecule are major determinants of the ability of the PMN protein to activate a given PLA2. Our results provide another demonstration that these important enzymes have diverged during evolution to perform different biological functions.


Assuntos
Fenômenos Fisiológicos Bacterianos , Proteínas de Membrana , Neutrófilos/enzimologia , Fosfolipases A/fisiologia , Fosfolipases/fisiologia , Animais , Peptídeos Catiônicos Antimicrobianos , Atividade Bactericida do Sangue/fisiologia , Proteínas Sanguíneas/fisiologia , Humanos , Neutrófilos/microbiologia , Neutrófilos/fisiologia , Fosfolipases A2
5.
Eur J Biochem ; 182(2): 307-13, 1989 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-2661228

RESUMO

In addition to the Ca2+ ion at the active site, porcine pancreatic phospholipase A2 (PLA) is known to bind a second calcium ion with a lower affinity at alkaline pH. The second calcium-binding site has been held responsible for effective interaction of phospholipase with organized lipid/water interfaces [van Dam-Mieras, M. C. E., Slotboom, A. J., Pieterson, W. A. and de Haas, G. H. (1975) Biochemistry 14, 5387-5394]. To study the identity of the acidic amino acid residues involved in liganding the second calcium ion in detail, we used site-directed mutagenesis to specifically alter the cDNA encoding porcine pancreatic phospholipase. Three mutant phospholipase species were constructed, each of which lacked one of the potentially important carboxylates: Asp66----Asn, Glu71----Asn and Glu92----Gln. The Gln92 mutant PLA displayed the same properties as native phospholipase indicating that Glu92 is not important for binding the second metal ion. However, Glu71 and, to a lesser extent, Asp66 are both directly involved in the low-affinity calcium binding.


Assuntos
Ácido Aspártico/farmacologia , Cálcio/metabolismo , Glutamatos/farmacologia , Pâncreas/enzimologia , Fosfolipases A/metabolismo , Fosfolipases/metabolismo , Animais , Sítios de Ligação/efeitos dos fármacos , Cálcio/farmacologia , DNA/metabolismo , Código Genético , Conformação Molecular , Mutação , Fosfolipases A/biossíntese , Fosfolipases A/genética , Fosfolipases A2 , Plasmídeos , Saccharomyces cerevisiae/metabolismo , Suínos , Transfecção
6.
J Cell Biochem ; 39(4): 379-90, 1989 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-2722967

RESUMO

The role of aspartic acid-49 (Asp-49) in the active site of porcine pancreatic phospholipase A2 was studied by recombinant DNA techniques: two mutant proteins were constructed containing either glutamic acid (Glu) or lysine (Lys) at position 49. Enzymatic characterization indicated that the presence of Asp-49 is essential for effective hydrolysis of phospholipids. Conversion of Asp-49 to either Glu or Lys strongly reduces the binding of Ca2+ ions, in particular for the lysine mutant, but the affinity for substrate analogues is hardly affected. Extensive purification of naturally occurring Lys-49 phospholipase A2 from the venom of Agkistrodon piscivorus piscivorus yielded a protein that was nearly inactive. Inhibition studies showed that this residual activity was due to a small amount of contaminating enzyme and that the Lys-49 homologue itself has no enzymatic activity. Our results indicate that Asp-49 is essential for the catalytic action of phospholipase A2. The importance of Asp-49 was further evaluated by comparison of the primary sequences of 53 phospholipases A2 and phospholipase homologues showing that substitutions at position 49 are accompanied by structural variations of otherwise conserved residues. The occurrence of several nonconserved substitutions appeared to be a general characteristic of nonactive phospholipase A2 homologues.


Assuntos
Aminoácidos/fisiologia , Ácido Aspártico/fisiologia , Fosfolipases A/metabolismo , Fosfolipases/metabolismo , Sequência de Aminoácidos , Animais , Cálcio/metabolismo , Cromatografia por Troca Iônica , Cinética , Dados de Sequência Molecular , Pâncreas/enzimologia , Fosfolipases A2 , Suínos
7.
Eur J Biochem ; 176(2): 353-7, 1988 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-3046944

RESUMO

In order to probe the role of Asp-49 in the active site of porcine pancreatic phospholipase A2 two mutant proteins were constructed containing either Glu or Lys at position 49. Their enzymatic activities and their affinities for substrate and for Ca2+ ions were examined in comparison with the native enzyme. Enzymatic characterization indicated that the presence of Asp-49 is essential for effective hydrolysis of phospholipids. Conversion of Asp-49 to either Glu or Lys strongly reduces the binding of Ca2+ ions in particular for the lysine mutant but the affinity for substrate analogues is hardly affected. Extensive purification of [Lys49]phospholipase A2 from the venom of Agkistrodon piscivorus piscivorus yielded a protein which was 4000 times less active than the basic [Asp49]phospholipase A2 from this venom. Inhibition studies with p-bromophenacyl bromide showed that this residual activity was due to a small amount of contaminating enzyme and that the Lys-49 homologue itself is inactive. The results obtained both with the porcine pancreatic phospholipase A2 mutants and with the native venom enzymes show that Asp-49 is essential for the catalytic action of phospholipase A2.


Assuntos
Ácido Aspártico/fisiologia , Venenos de Crotalídeos/análise , Pâncreas/enzimologia , Fosfolipases A/metabolismo , Fosfolipases/metabolismo , Sequência de Aminoácidos , Animais , Sítios de Ligação , Cálcio/metabolismo , Fenômenos Químicos , Química , Escherichia coli/genética , Regulação da Expressão Gênica , Concentração de Íons de Hidrogênio , Hidrólise , Mutação , Fosfolipases A/genética , Fosfolipases A2 , Fosfolipídeos/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Saccharomyces cerevisiae/genética , Suínos
8.
Eur J Biochem ; 170(1-2): 241-6, 1987 Dec 30.
Artigo em Inglês | MEDLINE | ID: mdl-3319617

RESUMO

The cDNA coding for porcine pancreatic prophospholipase A2 (proPLA) has been cloned and expressed in Saccharomyces cerevisiae. Expression and secretion of proPLA could only be obtained after fusing the proPLA to the prepro sequence of the yeast alpha-mating factor. Upon secretion, the fusion protein was cleaved by the KEX2 protease yielding a 140-amino-acid zymogen-like form of the phospholipase A2. This protein was purified in high yield by ion-exchange chromatography. Limited proteolysis with trypsin cleaved the 'zymogen' to yield active phospholipase A2, which was indistinguishable from the authentic porcine pancreatic enzyme. These results show that a protein with a disulphide bridge content as high as 7 per 124 amino acid residues can be correctly processed by the yeast secretory apparatus.


Assuntos
Peptídeos/genética , Fosfolipases A/genética , Fosfolipases/genética , Saccharomyces cerevisiae/genética , Animais , Escherichia coli/genética , Fator de Acasalamento , Pâncreas/enzimologia , Fosfolipases A/biossíntese , Fosfolipases A2 , Plasmídeos , Precursores de Proteínas/genética , Proteínas Recombinantes/biossíntese , Suínos
9.
Nucleic Acids Res ; 15(9): 3743-59, 1987 May 11.
Artigo em Inglês | MEDLINE | ID: mdl-3295782

RESUMO

The cDNA coding for the porcine pancreatic prophospholipase A2 (proPLA) has been cloned and expressed in E. coli. Expression of proPLA could only be obtained in the form of intracellular aggregates after fusing the 15 kDa proPLA to a large (greater than or equal to 45 kDa) bacterial peptide. The fusion protein was readily purified from cell lysates, and specifically cleaved. Cleavage of the fusion protein was achieved with either hydroxylamine (at Asn/Gly sequences in the denatured protein), or trypsin (between the pro- and the mature PLA in the renatured fusion protein). The former method releases a proPLA-like enzyme, while the latter directly yields PLA. Renaturation of the fusion protein was made possible by the use of a recently reported new S-sulphonation method. The released (pro)PLA was purified (yields of 2-3 mg/ltr of culture medium), and showed identical properties compared to native (pro)PLA.


Assuntos
Fosfolipases A/biossíntese , Fosfolipases/biossíntese , Precursores de Proteínas/metabolismo , Proteínas Recombinantes de Fusão/metabolismo , Proteínas Recombinantes/metabolismo , Sequência de Aminoácidos , Animais , Sequência de Bases , DNA/genética , Ativação Enzimática/efeitos dos fármacos , Escherichia coli/metabolismo , Hidroxilamina , Hidroxilaminas/farmacologia , Fosfolipases A/genética , Fosfolipases A2 , Precursores de Proteínas/genética , Processamento de Proteína Pós-Traducional , Proteínas Recombinantes de Fusão/genética , Suínos , Tripsina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...